These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9356038)

  • 1. Renal and ocular hemodynamic effects of insulin.
    Schmetterer L; Müller M; Fasching P; Diepolder C; Gallenkamp A; Zanaschka G; Findl O; Strenn K; Mensik C; Tschernko E; Eichler HG; Wolzt M
    Diabetes; 1997 Nov; 46(11):1868-74. PubMed ID: 9356038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man.
    Schmetterer L; Krejcy K; Kastner J; Wolzt M; Gouya G; Findl O; Lexer F; Breiteneder H; Fercher AF; Eichler HG
    Exp Eye Res; 1997 Mar; 64(3):305-12. PubMed ID: 9196381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
    Dorner GT; Garhöfer G; Selenko N; Fasching P; Bayerle-Eder M; Schmetterer L; Wolzt M
    Graefes Arch Clin Exp Ophthalmol; 2003 Aug; 241(8):619-24. PubMed ID: 12836035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans.
    Dallinger S; Sieder A; Strametz J; Bayerle-Eder M; Wolzt M; Schmetterer L
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1106-11. PubMed ID: 12736155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and ocular blood flow in patients with IDDM.
    Schmetterer L; Findl O; Fasching P; Ferber W; Strenn K; Breiteneder H; Adam H; Eichler HG; Wolzt M
    Diabetes; 1997 Apr; 46(4):653-8. PubMed ID: 9075807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans.
    Schmetterer L; Findl O; Strenn K; Graselli U; Kastner J; Eichler HG; Wolzt M
    Am J Physiol; 1997 Dec; 273(6):R2005-12. PubMed ID: 9435655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide release accounts for insulin's vascular effects in humans.
    Scherrer U; Randin D; Vollenweider P; Vollenweider L; Nicod P
    J Clin Invest; 1994 Dec; 94(6):2511-5. PubMed ID: 7989610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
    Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
    Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
    Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
    Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
    Steinberg HO; Brechtel G; Johnson A; Fineberg N; Baron AD
    J Clin Invest; 1994 Sep; 94(3):1172-9. PubMed ID: 8083357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.
    Shankar R; Zhu JS; Ladd B; Henry D; Shen HQ; Baron AD
    J Clin Invest; 1998 Oct; 102(7):1403-12. PubMed ID: 9769333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.
    Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB
    Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal resistive index--a valid tool to assess renal endothelial function in humans?
    Raff U; Schwarz TK; Schmidt BM; Schneider MP; Schmieder RE
    Nephrol Dial Transplant; 2010 Jun; 25(6):1869-74. PubMed ID: 20142629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans.
    Dijkhorst-Oei LT; Rabelink TJ; Boer P; Koomans HA
    Hypertension; 1997 May; 29(5):1192-8. PubMed ID: 9149686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats.
    Kvam FI; Ofstad J; Iversen BM
    Kidney Blood Press Res; 2000; 23(6):376-84. PubMed ID: 11070417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
    Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Diamant M; Joles JA; van Raalte DH
    Diabetes Obes Metab; 2016 Feb; 18(2):178-85. PubMed ID: 26636423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery.
    Dorner GT; Garhöfer G; Huemer KH; Golestani E; Zawinka C; Schmetterer L; Wolzt M
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3947-51. PubMed ID: 12939313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.